Cinfa outlines biosimilar development areas and deal opportunities

November 24, 2016 Christoph Graener

 

Cinfa Biotech’s managing director, Ruediger Jankowsky, chats with Mike Ward, global director of content for Informa Pharma Intelligence, about the company’s founding and focus on biosimilar drug development. They discuss Cinfa’s biosimilars business model, disease areas of focus and potential deals for the company in the near future.



Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Ruediger Jankowsky – Managing Director, Cinfa Biotech

 

Previous Article
Neovacs CEO outlines clinical timeline for lupus drug
Neovacs CEO outlines clinical timeline for lupus drug

Miguel Sieler, CEO of 25-year-old French vaccines company Neovacs, discusses the company's early lead in im...

Next Video
BIO-Europe® 2016: The new frontier: Aging and health
BIO-Europe® 2016: The new frontier: Aging and health

An increasing older population is characteristic of many countries in Europe and around the world. The stra...